相关实验视频

Updated: May 12, 2026

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

解读乳腺癌的动态:从单细胞和空间分析的洞察力,在多omics时代

Xin Xiong¹, Xin Wang², Cui-Cui Liu¹

¹Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Cancer Institute, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.

Biomarker research

|September 18, 2024

概括

单细胞测序 (SCS) 和空间奥米克为研究乳腺癌提供了新的途径. 这些先进的技术为瘤行为提供了深刻的见解,有助于未来的诊断和治疗.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
生物技术是生物技术.

背景情况:

乳腺癌是女性常见的瘤,转移和耐药性带来临床挑战.
了解瘤病原和异质性对于有效治疗至关重要.
单细胞测序 (SCS) 技术在单个细胞水平上提供高通量分子洞察力.

研究的目的:

提供关于SCS历史发展的全面概述.
为突出乳腺癌研究中SCS和空间空间学的最新进展.
作为未来乳腺癌研究,诊断和治疗方面的进展的参考.

主要方法:

审查单细胞测序 (SCS) 技术的发展.
对最近使用SCS和空间奥米克在乳腺癌中的研究进行分析.
集成多时点采样和空间奥米克用于细胞动态.

主要成果:

SCS为恶性瘤生物学提供了前所未有的洞察力.
空间奥米克增强了对时间和空间维度中的细胞动态的理解.
最近的进展为乳腺癌研究提供了宝贵的数据.

结论:

SCS和空间奥米克是了解乳腺癌的变革性工具.
这些技术对于推进基础研究,临床诊断和治疗策略至关重要.
未来的研究将从这些先进的测序方法所提供的全面见解中受益.

关键词:

乳腺癌乳腺癌乳腺癌单细胞测序是一种单细胞测序.空间奥米克斯空间奥米克斯瘤异质性瘤异质性

更多相关视频

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection

Published on: July 6, 2022

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

相关概念视频

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...